The New Definition of Pulmonary Hypertension: How Are Pre- and Post-Capillary Disease Separated?

The New Definition of Pulmonary Hypertension: How Are Pre- and Post-Capillary Disease Separated?

Article ID

ITL-e4bf8ba46c24

Language
English
Specialty
Cardiac
Updated
November 18, 2026

Juan Li, MD · Updated November 18, 2026

In the Literature · 中文版

Watch the video

Watch on YouTube

The new hemodynamic definition of pulmonary hypertension: mean pulmonary artery pressure above 20 mmHg defines PH, a wedge pressure of 15 mmHg separates pre- from post-capillary disease, and pulmonary vascular resistance above 2 Wood units marks a pre-capillary component, including combined pre- and post-capillary PH.
The new hemodynamic definition of pulmonary hypertension: mean pulmonary artery pressure above 20 mmHg defines PH, a wedge pressure of 15 mmHg separates pre- from post-capillary disease, and pulmonary vascular resistance above 2 Wood units marks a pre-capillary component, including combined pre- and post-capillary PH.

Key points

  • The threshold has fallen. PH now includes a mean pulmonary artery pressure above 20 mm Hg, and PVR above 2.0 Wood units is used for diagnosis and prognosis.[1]
  • The reason is data, not convenience. Normal mPAP is about 14.0 mmHg, and the old PVR cut-off of 3 WU was called arbitrary.[2]
  • Three numbers sort the categories. Combined pre- and post-capillary PH requires mPAP above 20, wedge pressure above 15 mmHg and PVR above 2 WU.[3]
  • Left heart disease dominates. It is the most prevalent cause of PH, and in group 2 PH, PAH-targeted therapies have no clear role.[3], [4]
  • The net is wider. The revised definition captures about 60% more patients, and in one transplant cohort 47% of isolated post-capillary cases were reclassified as combined.[1], [5]

Before mitral valve surgery, right heart catheterization shows a mean pulmonary artery pressure of 28 mmHg, a wedge pressure of 22 mmHg and a PVR of 2.5 Wood units. Under the new definition, is this isolated post-capillary or combined pre- and post-capillary pulmonary hypertension?[1], [3]

Why the thresholds changed

Maron explains that PH now includes a mean pulmonary artery pressure above 20 mm Hg and that PVR above 2.0 Wood units is used for diagnosis and prognosis, because mortality rises continuously above 2.0 WU.[1] Simonneau and colleagues, analysing 1187 normal subjects from 47 studies, found a normal mPAP of 14.0 mmHg; they called the 3 WU cut-off arbitrary, noted that PVR above 2 WU could be abnormal, and found that patients with mPAP of 21 to 24 mmHg had a median PVR of 2.7 WU. In 2019 they defined pre-capillary PH as mPAP above 20 mmHg together with other criteria, but judged that too many uncertainties prevented reintroducing a definition of exercise PH.[2]

How the hemodynamic thresholds for pulmonary hypertension changed.
How the hemodynamic thresholds for pulmonary hypertension changed.

Figure 1. Lower thresholds, grounded in normal data. Synthesized from Maron and Simonneau et al.[1], [2] View larger.

Sorting pre- from post-capillary disease

Mohananey and colleagues summarize the 2022 European definitions: PH is mPAP above 20 mmHg; combined pre- and post-capillary PH requires mPAP above 20 mmHg, wedge pressure above 15 mmHg and PVR above 2 WU; a precapillary component is identified by PVR above 2 WU; and exercise PH is an mPAP/cardiac output slope above 3 mmHg/L/min. Left heart disease is the most prevalent cause, and a PVR above 5 WU may better predict outcomes.[3] The AHA statement on noncardiac surgery adopted PVR above 2 WU instead of 3 WU, notes that higher mPAP is consistently associated with mortality and that combined PH can involve pulmonary vascular remodeling, and states that in group 2 PH, PAH-targeted therapies have no clear role.[4]

Categories of pulmonary hypertension under the 2022 definitions.
Categories of pulmonary hypertension under the 2022 definitions.

Figure 2. Wedge pressure first, then resistance. Synthesized from Mohananey et al., Rajagopal et al. and Maron.[3], [4], [1] View larger.

What the new definition changes

Maron estimates that the revised definition captures about 60% more patients.[1] Corianò and colleagues applied it to 357 heart transplant candidates: 65 had no PH, 84 isolated post-capillary PH and 208 combined PH; 74 (47%) moved from isolated to combined PH, only mPAP above 20 mmHg was associated with 1-year mortality (HR 4.31), and the updated classification did not discriminate risk better (C-statistic 0.591).[5]

Impact of the revised definition on classification and risk.
Impact of the revised definition on classification and risk.

Figure 3. More patients, similar discrimination. Redrawn from Corianò et al. and Maron.[5], [1] View larger.

Three takeaways

  1. PH is mPAP above 20 mmHg; check the wedge pressure, then the PVR.[1], [3]
  2. With wedge pressure above 15 mmHg, PVR above 2 WU means combined pre- and post-capillary PH.[3]
  3. Lower thresholds widen the net; their effect on management and risk is still being tested.[1], [5]

References

  1. Maron BA. Revised definition of pulmonary hypertension and approach to management: a clinical primer. J Am Heart Assoc. 2023;12(8):e029024. doi:10.1161/JAHA.122.029024
  2. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. doi:10.1183/13993003.01913-2018
  3. Mohananey D, Martin AK, Mandawat H, et al. Analysis of the 2022 European Society of Cardiology/European Respiratory Society guidelines for the diagnosis and treatment of pulmonary hypertension. J Cardiothorac Vasc Anesth. 2024;38(2):534–541. doi:10.1053/j.jvca.2023.10.037
  4. Rajagopal S, Ruetzler K, Ghadimi K, et al. Evaluation and management of pulmonary hypertension in noncardiac surgery: a scientific statement from the American Heart Association. Circulation. 2023;147(17):1317–1343. doi:10.1161/CIR.0000000000001136
  5. Corianò M, Pradegan N, Putortì F, et al. Risk stratification of adverse outcomes after heart transplantation with the 2022 definition of pulmonary hypertension. J Cardiovasc Dev Dis. 2026;13(6):227. doi:10.3390/jcdd13060227